198 related articles for article (PubMed ID: 17890173)
1. [Cost differences in the treatment of severe sepsis between survivors and non-survivors on the first day of intensive care admission].
Csomós A; Szentkereszty Z; Fülesdi B
Orv Hetil; 2007 Sep; 148(39):1851-6. PubMed ID: 17890173
[TBL] [Abstract][Full Text] [Related]
2. [The incidence and cost of severe sepsis in intensive care units].
Csomós A; Hoffer G; Fülesdi B; Ludwig E
Orv Hetil; 2005 Jul; 146(29):1543-7. PubMed ID: 16136776
[TBL] [Abstract][Full Text] [Related]
3. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
Degoricija V; Sharma M; Legac A; Gradiser M; Sefer S; Vucicević Z
Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
[TBL] [Abstract][Full Text] [Related]
4. Primary sepsis in a university hospital in northern Sweden: a retrospective study.
Jacobson S; Johansson G; Winsö O
Acta Anaesthesiol Scand; 2004 Sep; 48(8):960-7. PubMed ID: 15315612
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness analysis of an initial ICU admission as compared to a delayed ICU admission in patients with severe sepsis or in septic shock.
Champunot R; Thawitsri T; Kamsawang N; Sirichote V; Nopmaneejumruslers C
J Med Assoc Thai; 2014 Jan; 97 Suppl 1():S102-7. PubMed ID: 24855849
[TBL] [Abstract][Full Text] [Related]
6. Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy.
Burchardi H; Schneider H
Pharmacoeconomics; 2004; 22(12):793-813. PubMed ID: 15294012
[TBL] [Abstract][Full Text] [Related]
7. Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use.
Moerer O; Schmid A; Hofmann M; Herklotz A; Reinhart K; Werdan K; Schneider H; Burchardi H
Intensive Care Med; 2002 Oct; 28(10):1440-6. PubMed ID: 12373469
[TBL] [Abstract][Full Text] [Related]
8. Effects of severity of illness on resource use by survivors and nonsurvivors of severe sepsis at intensive care unit admission.
Teres D; Rapoport J; Lemeshow S; Kim S; Akhras K
Crit Care Med; 2002 Nov; 30(11):2413-9. PubMed ID: 12441747
[TBL] [Abstract][Full Text] [Related]
9. A multicentre, prospective study to evaluate costs of septic patients in Brazilian intensive care units.
Sogayar AM; Machado FR; Rea-Neto A; Dornas A; Grion CM; Lobo SM; Tura BR; Silva CL; Cal RG; Beer I; Michels V; Safi J; Kayath M; Silva E;
Pharmacoeconomics; 2008; 26(5):425-34. PubMed ID: 18429658
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of illness imposed by severe sepsis in Austria.
Schmid A; Schneider H; Adlof A; Smolle KH; Edelmann G; Sporn P; Frass M; Sumann G; Koller W; Schobersberger W
Wien Klin Wochenschr; 2002 Aug; 114(15-16):697-701. PubMed ID: 12602114
[TBL] [Abstract][Full Text] [Related]
11. The patient-related costs of care for sepsis patients in a United Kingdom adult general intensive care unit.
Edbrooke DL; Hibbert CL; Kingsley JM; Smith S; Bright NM; Quinn JM
Crit Care Med; 1999 Sep; 27(9):1760-7. PubMed ID: 10507595
[TBL] [Abstract][Full Text] [Related]
12. [Treatment costs in a medical intensive care unit: a comparison of 1992 and 1997].
Klepzig H; Winten G; Thierolf C; Kiesling G; Usadel KH; Zeiher AM
Dtsch Med Wochenschr; 1998 Jun; 123(23):719-25. PubMed ID: 9651569
[TBL] [Abstract][Full Text] [Related]
13. Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness.
Granja C; Dias C; Costa-Pereira A; Sarmento A
Crit Care; 2004 Apr; 8(2):R91-8. PubMed ID: 15025783
[TBL] [Abstract][Full Text] [Related]
14. Cost of Gram-negative resistance.
Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
[TBL] [Abstract][Full Text] [Related]
15. A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units.
Moerer O; Plock E; Mgbor U; Schmid A; Schneider H; Wischnewsky MB; Burchardi H
Crit Care; 2007; 11(3):R69. PubMed ID: 17594475
[TBL] [Abstract][Full Text] [Related]
16. Cost savings attributable to reductions in intensive care unit length of stay for mechanically ventilated patients.
Kahn JM; Rubenfeld GD; Rohrbach J; Fuchs BD
Med Care; 2008 Dec; 46(12):1226-33. PubMed ID: 19300312
[TBL] [Abstract][Full Text] [Related]
17. The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis.
Brun-Buisson C; Roudot-Thoraval F; Girou E; Grenier-Sennelier C; Durand-Zaleski I
Intensive Care Med; 2003 Sep; 29(9):1464-71. PubMed ID: 12856120
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and efficiency of intensive care medicine: variable costs in different diagnosis groups.
Iapichino G; Radrizzani D; Simini B; Rossi C; Albicini M; Ferla L; Colombo A; Pezzi A; Brazzi L; Melotti R; Rossi G;
Acta Anaesthesiol Scand; 2004 Aug; 48(7):820-6. PubMed ID: 15242425
[TBL] [Abstract][Full Text] [Related]
19. Cost of intensive care unit-acquired bloodstream infections.
Laupland KB; Lee H; Gregson DB; Manns BJ
J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
[TBL] [Abstract][Full Text] [Related]
20. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study.
Garnacho-Montero J; Ortiz-Leyba C; Herrera-Melero I; Aldabó-Pallás T; Cayuela-Dominguez A; Marquez-Vacaro JA; Carbajal-Guerrero J; Garcia-Garmendia JL
J Antimicrob Chemother; 2008 Feb; 61(2):436-41. PubMed ID: 18056733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
